Osseodensification vs Conventional Drilling for Immediate Dental Implant Placement: A Randomized Controlled Clinical and Radiographic Study
Launched by MOHAMAD ALI ITANI · Jul 12, 2025
Trial Information
Current as of July 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
A bifurcation inter-radicular bone of 2 mm or more in a none restorable lower molar will be needed in order to successfully be able to drill the bone with conventional or Osseo densification burs, followed by placing the implant at this site. A xenograft bone material will be used to fill the extraction socket and a customized temporary abutment using flowable composite and a silicone mold will be fabricated and placed over it after polishing it.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patient age 25 to 45 years old
- • 2. Systemically and periodontally healthy individuals.
- • 3. Non-smokers or light smokers (Less than 5 cigarettes a day) (Schane 2010).
- • 4. Good oral hygiene.
- • 5. Healthy remaining dentition.
- • 6. Adequate quality and quantity of bone
- • 7. Interradicular septum ≥ 2 mm (Bleyan, 2022).
- • 8. Mandibular non-restorable molars.
- • 9. Type A or B socket (Smith and Tarnow, 2013).
- Exclusion Criteria:
- • 1. Acute inflammation or infection in the implant region.
- • 2. Patients with mental disorders who could not cooperate with treatment or communicate normally.
- • 3. Patients who have severe systemic disorders (Uncontrolled Diabetes, Uncontrolled Hypertension, End stage kidney or liver diseases and Severe Heart diseases) .
- • 4. Poor oral hygiene.
- • 5. Active periodontal disease.
- • 6. Uncooperative patients, not willing to adhere to post-surgical instructions and follow up visits.
About Mohamad Ali Itani
Mohamad Ali Itani is a clinical trial sponsor dedicated to advancing medical research through the development and support of innovative clinical studies. With a focus on improving patient outcomes and contributing to evidence-based medicine, Mohamad Ali Itani collaborates with healthcare professionals and research institutions to ensure the successful design, implementation, and management of clinical trials across various therapeutic areas.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beirut, , Lebanon
Patients applied
Trial Officials
Nayer Aboelsaad, Phd
Study Chair
Beirut Arab Univeristy
Rania Abdelaziz, Phd
Study Director
Beirut Arab University
Hani Arakji, Phd
Study Director
Beirut Arab University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported